Does Zokinvy 75 Mg Capsule Progeria Syndrome Treatment Agents Interact with other Medications?
Severe Interactions
These medications are not usually taken together. Consult your healthcare professional (e.g., doctor or pharmacist) for more in formation.
- LONAFARNIB/STRONG AND MODERATE CYP3A4 INHIBITORS
- LONAFARNIB/STRONG AND MODERATE CYP3A4 INDUCERS
- LONAFARNIB/ORAL LEFAMULIN
- STRONG CYP3A4 INHIBITORS/GEPIRONE
- SELECTED STRONG AND MODERATE CYP3A4 INHIBITORS/CISAPRIDE
- STR 3A4 INHIB;ATAZAN;DARUN/COLCHICINE (FOR CARDIOPROTECTION)
- SELECTED IMMUNOSUPPRESSANTS/NADOFARAGENE FIRADENOVEC
- STR CYP3A4 INHIBITORS; PROTEASE INHIB/PIMAVANSERIN (> 10 MG)
- STRONG CYP3A4 INHIBITORS/MAVACAMTEN
- STRONG CYP3A4 INHIBITORS/PACRITINIB
- LONAFARNIB/MITAPIVAT
- STRONG CYP3A4 INHIBITORS/DARIDOREXANT
- LONAFARNIB/LEVOKETOCONAZOLE
- SELECTED STRONG CYP3A4 INHIBITORS/CONIVAPTAN
- SELECTED STRONG CYP3A4 INHIBITORS/ALFUZOSIN
- STRONG CYP3A4 INHIBITORS/FINERENONE
- STRONG CYP3A4 INHIBITORS/VOCLOSPORIN
- LONAFARNIB/CILOSTAZOL (> 50 MG)
- LONAFARNIB/MIDAZOLAM
- LONAFARNIB/ATORVASTATIN; LOVASTATIN; SIMVASTATIN
- LONAFARNIB; TUCATINIB/PIMOZIDE
- STRONG CYP3A4 INHIB; PROTEASE INHIB/LUMATEPERONE (>10.5 MG)
- STRONG CYP3A4 INHIBITORS/UBROGEPANT
- SELECTED STRONG CYP3A4 INHIBITORS/ALPRAZOLAM; TRIAZOLAM
- STRONG CYP3A4 INHIBITORS; ATAZANAVIR;DARUNAVIR/LERCANIDIPINE
- STRONG CYP3A4 INHIBITORS/DAPAGLIFLOZIN-SAXAGLIPTIN-METFORMIN
- STRONG AND MODERATE CYP3A4 INHIBITORS/ASUNAPREVIR
- STRONG CYP3A4 INHIBITORS/VALBENAZINE (> 40 MG)
- STRONG OR MODERATE CYP3A4 INHIBITORS/LOMITAPIDE
- SELECTED IMMUNOSUPPRESSANTS/TALIMOGENE LAHERPAREPVEC
- STRONG CYP3A4 INHIBITORS/PANOBINOSTAT (> 10 MG)
- STRONG CYP3A4 INHIBITORS/NALOXEGOL
- STRONG CYP3A4 INHIBITORS; ATAZANAVIR; DARUNAVIR/AVANAFIL
- 3A4INHIB/DAPOXETINE;LEVOMILNACIPRAN(>80MG);VILAZODONE(>20MG)
- STRONG OR MODERATE CYP3A4 INHIBITORS/FLIBANSERIN
- SELECTED STRONG CYP3A4 INHIBITORS/ERGOT ALKALOIDS
- STRONG CYP3A4 INHIBITORS/SLT HIGH STRENGTH ANTIMUSCARINICS
- SELECTED STRONG AND MODERATE CYP3A4 INHIBITORS/DOMPERIDONE
- STRONG CYP3A4 INHIBITORS; PROTEASE INHIBITORS/TICAGRELOR
- SELECTED STRONG CYP3A4 INHIBITORS/LURASIDONE
- STRONG CYP3A4 INHIB;ATAZANAV;DARUNAVIR/SAXAGLIPTIN (>2.5 MG)
- STRONG CYP3A4 INHIBITORS; DARUNAVIR/DRONEDARONE
- P-GP AND STRONG CYP3A4 INHIBITORS/RIVAROXABAN
- SELECTED IMMUNOSUPPRESSIVE AGENTS/LIVE VACCINES; LIVE BCG
- STRONG CYP3A4 INHIBITORS; PROTEASE INHIBITORS/RANOLAZINE
- STRONG CYP3A4 INHIBITORS/TOLVAPTAN
- STRONG CYP3A4 INHIBITORS; PROTEASE INHIBITORS/IVABRADINE
- IMMUNOSUPPRESSIVES; IMMUNOMODULATORS/EFALIZUMAB; NATALIZUMAB
- STRONG CYP3A4 INHIBITORS/SILODOSIN; TAMSULOSIN
- STRONG CYP3A4 INHIBITORS; PROTEASE INHIBITORS/EPLERENONE
- STRONG CYP3A4 INHIBITORS/IRINOTECAN
- STRONG CYP3A4 INHIBITORS/VARDENAFIL (>2.5 MG)
Serious Interactions
These medications may interact and cause very harmful effects. Consult your healthcare professional (e.g., doctor or pharmacist) for more in formation.
- LONAFARNIB/WEAK CYP3A4 INHIBITORS
- LONAFARNIB/PIRTOBRUTINIB
- LONAFARNIB/CAPIVASERTIB
- IMMUNOSUPPRESSIVE CYP3A4 INHIBITORS/ETRASIMOD
- STRONG CYP3A4 OR MODERATE CYP2C9 INHIBITORS/ERDAFITINIB
- STRONG CYP3A4 INHIBITORS/REBOXETINE
- SELECTED CYP3A4 INHIBITORS/MEPERIDINE
- STRONG CYP3A4 INHIBITORS/PALOVAROTENE
- IMMUNOSUPPRESSIVES; IMMUNOMODULATORS/RITLECITINIB
- STRONG CYP3A4 INHIBITORS/TRETINOIN
- STRONG AND MODERATE CYP3A4 INHIBITORS/ELACESTRANT
- DUAL STRONG CYP3A4 & P-GP INHIBITORS/FUTIBATINIB
- MYELOSUPPRESSIVE STRONG CYP3A4 INHIBITORS/CLOZAPINE
- STRONG CYP3A4 INHIBITOR/TOLTERODINE (>1 MG IR OR >2 MG ER)
- STRONG CYP3A4 INHIBITORS/RIVOCERANIB
- STRONG CYP3A4 INHIBITORS/UPADACITINIB (>=30 MG)
- STRONG CYP3A4 INHIBITORS/RUPATADINE
- LONAFARNIB/AVACOPAN
- STRONG CYP3A4 INHIBITORS/SURUFATINIB
- STRONG CYP3A4 INHIBITORS/MOBOCERTINIB
- IMMUNOSUPPRESSIVES; IMMUNOMODULATORS/CLADRIBINE
- IMMUNOSUPPRESSIVES; IMMUNOMODULATORS/SIPONIMOD
- IMMUNOSUPPRESSIVES; IMMUNOMODULATORS/OZANIMOD
- IMMUNOSUPPRESSIVES; IMMUNOMODULATORS/FINGOLIMOD
- MYELOSUPPRESSIVES; IMMUNOMODULATORS/SODIUM IODIDE I 131
- IMMUNOSUPPRESSIVES; IMMUNOMODULATORS/FILGOTINIB
- STRONG AND MODERATE CYP3A4 INHIBITORS/INFIGRATINIB
- IMMUNOSUPPRESSIVES; IMMUNOMODULATORS/PONESIMOD
- P-GLYCOPROTEIN (P-GP) INHIBITORS/RELUGOLIX
- STRONG CYP3A4 INHIBITORS/TOREMIFENE
- STRONG CYP3A4 INHIBITORS/SUNITINIB
- LONAFARNIB/PAZOPANIB
- LONAFARNIB/LAPATINIB
- STRONG CYP3A4 INHIBITORS/DASATINIB
- LONAFARNIB/PALBOCICLIB
- LONAFARNIB/OLAPARIB
- STRONG CYP3A4 INHIBITORS/VINFLUNINE
- STRONG CYP3A4 INHIBITORS/VINCRISTINE
- STRONG CYP3A4 INHIBITORS/VINBLASTINE
- STRONG CYP3A4 INHIBITORS/TOFACITINIB
- STRONG CYP3A4 INHIBITORS/SONIDEGIB
- STRONG CYP3A4 INHIBITORS/RUXOLITINIB
- STRONG CYP3A4 INHIBITORS/PONATINIB
- STRONG CYP3A4 INHIBITORS/PACLITAXEL
- STRONG CYP3A4 INHIBITORS/IXABEPILONE
- STRONG CYP3A4 INHIBITORS/ERLOTINIB
- STRONG CYP3A4 INHIBITORS/DOXORUBICIN
- STRONG CYP3A4 INHIBITORS/DOCETAXEL
- STRONG CYP3A4 INHIBITORS/COBIMETINIB
- STRONG CYP3A4 INHIBITORS/CABOZANTINIB
- STRONG CYP3A4 INHIBITORS/CABAZITAXEL
- STRONG CYP3A4 INHIBITORS/AXITINIB
- LONAFARNIB/SUVOREXANT
- LONAFARNIB/CILOSTAZOL (<= 50 MG)
- LONAFARNIB/ENTRECTINIB
- LONAFARNIB/IVACAFTOR
- LONAFARNIB/FOSTAMATINIB
- LONAFARNIB/RIMEGEPANT
- LONAFARNIB/EVEROLIMUS
- LONAFARNIB/DACLATASVIR
- LONAFARNIB/TACROLIMUS
- LONAFARNIB/OSILODROSTAT
- LONAFARNIB/SIMEPREVIR
- LONAFARNIB/SELPERCATINIB
- LONAFARNIB/LAROTRECTINIB
- LONAFARNIB/SELECTED CYP3A4 SUBSTRATES THAT PROLONG QT
- LONAFARNIB/SELECTED CYP3A4 SUBSTRATES
- STRONG CYP3A4 AND P-GP INHIBITORS/PRALSETINIB
- STRONG CYP3A4 INHIBITORS/PLITIDEPSIN
- IMMUNOSUPPRESSIVES; IMMUNOMODULATORS/BARICITINIB
- STRONG CYP3A4 INHIBITORS/LURBINECTEDIN
- IMMUNOSUPPRESSIVES; IMMUNOMODULATORS/INEBILIZUMAB
- STRONG AND MODERATE CYP3A4 INHIBITORS/PEMIGATINIB
- STRONG AND MODERATE CYP3A4 INHIBITORS/SELUMETINIB
- STRONG CYP3A4 INHIBITORS/NIMODIPINE
- STRONG CYP3A4 INHIBITORS/TAZEMETOSTAT
- STRONG CYP3A4 INHIBITORS/AVAPRITINIB
- SELECTED CYP3A4 INHIBITORS/SALMETEROL COMBINATIONS
- STRONG AND MODERATE CYP3A4 INHIBITORS/LEMBOREXANT
- STRONG CYP3A4 INHIBITORS/ELEXACAFTOR-TEZACAFTOR-IVACAFTOR
- STRONG CYP3A4 INHIBITORS/NALDEMEDINE
- STRONG CYP3A4 INHIBITORS/BOSUTINIB
- STRONG CYP3A4 INHIBITORS/GLASDEGIB
- STRONG CYP3A4 INHIBITORS/ARIPIPRAZOLE LAUROXIL SUBMICRONIZED
- STRONG AND MODERATE CYP3A4 INHIBITORS/ENCORAFENIB
- STRONG AND MODERATE CYP3A4 INHIBITORS/TEZACAFTOR-IVACAFTOR
- SELECTED STRONG CYP3A4 INHIBITOR;PROTEASE INHIB/DISOPYRAMIDE
- STRONG CYP3A4 INHIBITORS/IBRUTINIB
- STRONG CYP3A4 INHIBITORS/ACALABRUTINIB
- STRONG CYP3A4 INHIBITORS/ABEMACICLIB
- STRONG CYP3A4 INHIBITORS/COPANLISIB
- STRONG CYP3A4 INHIB;MODERATE 3A4 & P-GP DUAL INHIB/NERATINIB
- STRONG CYP3A4 INHIBITORS/BRIGATINIB
- STRONG AND MODERATE CYP3A4 INHIBITORS/DEFLAZACORT
- SLT STRONG 3A4 INHIBITORS/SILDENAFIL(PAH);TADALAFIL(BPH,PAH)
- STRONG CYP3A4 INHIBITORS/VENETOCLAX
- STRONG CYP3A4 INHIBITORS/VEMURAFENIB
- STRONG CYP3A4 INHIBITORS/TRABECTEDIN
- STRONG CYP3A4 INHIBITORS; PROTEASE INHIBITORS/CARIPRAZINE
- IMMUNOSUPPRES;IMMUNOMODUL/SELECTED MULTIPLE SCLEROSIS AGENTS
- STRONG CYP3A4 INHIB;ATAZANAV;DARUNAVIR/BEDAQUILINE;DELAMANID
- STRONG CYP3A4 INHIBITORS/TRASTUZUMAB EMTANSINE
- STRONG 3A4 INHIBITORS/ESZOPICLONE > 2 MG; ZOPICLONE > 5 MG
- STRONG & MODERATE CYP3A4 INHIBITORS/ELIGLUSTAT
- STRONG CYP3A4 INHIBITORS; PROTEASE INHIBITORS/VORAPAXAR
- STRONG & MODERATE CYP3A4 INHIBITORS/GUANFACINE
- STRONG CYP3A4 INHIBITORS/MACITENTAN
- DUAL STRONG CYP3A4 INHIBITOR & P-GP INHIBITORS/RIOCIGUAT
- STRONG CYP3A4 INHIBITORS/QUETIAPINE
- P-GP AND STRONG CYP3A4 INHIBITORS/APIXABAN
- SELECTED CYP2C19 INHIBITORS/CLOPIDOGREL
- SELECTED MYELOSUPPRESSIVE AGENTS/DEFERIPRONE
- SELECT CYP2C19 INHIBITORS/CITALOPRAM (>20 MG)
- SELECTED STRONG CYP3A4 INHIBITORS/SALMETEROL
- P-GLYCOPROTEIN (P-GP) INHIBITORS/TOPOTECAN
- SELECTED P-GLYCOPROTEIN (P-GP) INHIBITORS/DABIGATRAN
- STRONG CYP3A4 INHIBITORS/MARAVIROC
- STRONG CYP3A4 INHIBITORS/COLCHICINE
- SELECTED CYP3A4 INHIBITORS/SELECTED OPIOIDS
- SELECTED CYP3A4 INHIBITORS/TRAZODONE
- SELECTED CYP3A4 INHIBITORS/SELECTED STEROIDS
Moderate Interactions
These medications may cause some risk when taken together. Consult your healthcare professional (e.g., doctor or pharmacist) for more in formation.
- STRONG CYP3A4 INHIBITORS/VAMOROLONE
- IMMUNOSUPPRESSIVES; IMMUNOMODULATORS/TOCILIZUMAB
- STRONG CYP3A4 INHIBITORS/ZURANOLONE
- STRONG CYP3A4 INHIBITORS/QUIZARTINIB
- STR CYP3A4 INHIB;ATAZAN;DARUNAV/SLT LONG-ACTING ARIPIPRAZOLE
- STRONG CYP3A4 INHIBITORS/BORTEZOMIB
- IMMUNOSUPPRESSIVES; IMMUNOMODULATORS/UBLITUXIMAB
- STRONG CYP3A4 INHIBITORS/VALBENAZINE (=< 40 MG)
- STRONG CYP3A4 INHIB; PROTEASE INHIB/LUMATEPERONE (<=10.5 MG)
- SELECTED CYP3A4 INHIBITORS/MOMETASONE
- IMMUNOSUPPRESSIVES; IMMUNOMODULATORS/SARILUMAB
- STRONG CYP3A4 INHIBITORS/GILTERITINIB
- STRONG CYP3A4 INHIBITORS/TOLTERODINE (<=1 MG OR <=2 MG ER)
- STRONG CYP3A4 INHIBITORS/UPADACITINIB (<30 MG)
- IMMUNOSUPPRESSIVES; IMMUNOMODULATORS/COVID-19 VACCINES
- STRONG CYP3A4 INHIBITORS/IBREXAFUNGERP
- STRONG CYP3A4 INHIBITORS/REPAGLINIDE
- SELECTED STRONG CYP3A4 INHIBITORS;PROTEASE INHIB/ILOPERIDONE
- STRONG CYP3A4 INHIBITORS; PROTEASE INHIBITORS/BREXPIPRAZOLE
- SELECTED CYP2C19 INHIBITORS/ESCITALOPRAM (<= 15 MG)
- SELECT P-GP INHIBITORS/EDOXABAN (<= 30 MG)
- SELECTED P-GLYCOPROTEIN (P-GP) INHIBITORS/BETRIXABAN
- STR CYP3A4 INHIBITORS;PROTEASE INHIB/PIMAVANSERIN (<= 10 MG)
- SELECT P-GP INHIBITORS/EDOXABAN (> 30 MG)
- P-GP AND SELECTED CYP3A4 INHIBITORS/NINTEDANIB
- STRONG 3A4 INHIB/LEVOMILNACIPRAN(<=80MG);VILAZODONE(<=20MG)
- P-GLYCOPROTEIN (P-GP) INHIBITORS/AFATINIB
- SELECTED CYP2C19 INHIBITORS/ESCITALOPRAM (> 15 MG)
- SELECTED CYP2C19 INHIBITORS/CITALOPRAM (<= 20 MG)
- STRONG CYP3A4 INHIBITORS/VARDENAFIL (<=2.5 MG)
- STRONG CYP3A4 INHIBITORS/PANOBINOSTAT (<= 10 MG)
- STRONG CYP3A4 INHIB;ATAZANAV;DARUNAVIR/SAXAGLIPTIN(<=2.5 MG)
- CYP3A4; CYP2C8; P-GLYCOPROTEIN (P-GP) INHIBITORS/LOPERAMIDE
- STRONG CYP3A4 INHIBITORS/BUSPIRONE
- STRONG CYP3A4 INHIBITORS/ESZOPICLONE; ZOPICLONE; ZOLPIDEM
- STRONG CYP3A4 INHIBITORS/CINACALCET
- STRONG CYP3A4 INHIBITORS; ATAZANAVIR; DARUNAVIR/ARIPIPRAZOLE
- STRONG CYP3A4 INHIBITORS/SLT LOW STRENGTH ANTIMUSCARINICS
- SLT STRONG CYP3A4 INHIBITORS/SILDENAFIL (ED); TADALAFIL (ED)
- SELECTED P-GLYCOPROTEIN (P-GP) INHIBITORS/ETOPOSIDE
Selected from data included with permission and copyrighted by First Databank, Inc. This copyrighted material has been downloaded from a licensed data provider and is not for distribution, except as may be authorized by the applicable terms of use.
CONDITIONS OF USE: The information in this database is intended to supplement, not substitute for, the expertise and judgment of healthcare professionals. The information is not intended to cover all possible uses, directions, precautions, drug interactions or adverse effects, nor should it be construed to indicate that use of a particular drug is safe, appropriate or effective for you or anyone else. A healthcare professional should be consulted before taking any drug, changing any diet or commencing or discontinuing any course of treatment.